hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (FDA) to manufacture ibuprofen and famotidine tablets, 800 mg/26.6 mg. (USRLD: Duexis ...

Zydus, a leading, discovery-based, global pharmaceutical company announced that the US FDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of ...

Zydus Lifesciences has secured USFDA approval to market its generic Ketoconazole Shampoo for treating dandruff and fungal ...

Shares of Zydus ... the US Food and Drug Administration (FDA) issued 10 observations for the drugmaker's injectables manufacturing unit in Gujarat's Vadodara. At 11.25 am, Zydus Life was trading ...

The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained during the early trading hours on Friday after the US Food and Drug Administration (FDA) approved ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Zydus Lifesciences Ltd received the “No Observation” from US Food and Drug Administration in its ... Between February 10-14, 2025, the US FDA conducted an inspection to ensure compliance ...

Zydus Lifesciences Limited received final approval from the US Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2 per cent, according to the announcement issued by the ...

ANVIMO has established bioequivalence with the reference drug, ensuring quality ... get access to affordable, life-saving treatment,” Dr. Sharvil Patel, MD of Zydus Lifesciences, said.

Zydus Lifesciences Ltd has received final approval from the United States Food and Drug Administration (USFDA) to produce the antifungal drug Ketoconazole Shampoo, 2%. The approval is valid for ...